Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Mexico Tech Monitor.
Press releases published on April 23, 2025

Breckenridge Distillery Announces Re-Release of Award-Winning Cognac Cask Finish Whiskey
BRECKENRIDGE, Colo., April 23, 2025 (GLOBE NEWSWIRE) -- Breckenridge Distillery, one of the most-awarded craft distilleries in the U.S., and a Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY) spirits brand, today announced its newest addition to the brand …

Skyhawk Expands AI-powered Purple Team to Secure Custom Cloud Applications
SAN FRANCISCO, April 23, 2025 (GLOBE NEWSWIRE) -- RSA CONFERENCE, Skyhawk Security, the originator of Cloud Detection and Response (CDR), announces a revolutionary leap in cloud security with the expansion of its AI-powered Autonomous Purple Team to …

Seres Therapeutics to Announce First Quarter 2025 Financial Results and Business Updates on May 7, 2025
CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will host a conference call and live audio webcast on May 7, 2025 at 8:30 a.m. ET to …

Tiziana Life Sciences Announces University of Massachusetts Commences Dosing Intranasal Foralumab in Phase 2 Multiple Sclerosis Trial
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …

Aerodays 2025: Eine Konferenz über die Zukunft der europäischen Luftfahrt findet zum ersten Mal in Polen statt
WARSCHAU, Polen, April 23, 2025 (GLOBE NEWSWIRE) -- „Europa erobert den Himmel: Nachhaltigkeit und Wettbewerbsfähigkeit der Luftfahrt in einer sich wandelnden Welt“ lautet das Motto der Aerodays 2025 (Europäische Luftfahrt-Tage), einem internationalen …

Aerodays 2025 : la Pologne est pour la première fois l’hôte d’une conférence sur l’avenir de l’aéronautique européenne
VARSOVIE, Pologne, 23 avr. 2025 (GLOBE NEWSWIRE) -- Événement international dédié au secteur aéronautique, les Aerodays 2025 (Journées européennes de l’aéronautique) se tiendront du 7 au 9 mai 2025 à Varsovie et auront pour thème : « L’Europe à la pointe …

Coave Therapeutics Expands into the US with Strategic Appointment of Romain Pettenaro as VP of Business Development
Highly experienced in gene therapy dealmaking, Pettenaro will be driving Coave’s business development activities and establish its presence in the Boston biotech hub Paris, France, and Cambridge, MA, USA - April 23, 2025 – Coave Therapeutics (‘Coave’), a …

Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
LOUISVILLE, Colo. and HERCULES, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc (Nasdaq: BDSX), a leading diagnostics solutions company, and Bio-Rad Laboratories (NYSE: BIO), a global leader in life science research and diagnostics products, …

Port of Helsingborg Advances Digital Transformation with N4 Terminal Operating System, Reduces Rehandles by 50 Percent
HELSINGBORG, Sweden, April 23, 2025 (GLOBE NEWSWIRE) -- Port of Helsingborg, Sweden's second largest container terminal, continues to advance its modernization initiatives using the N4 Terminal Operating System (TOS) from Kaleris, a leading provider of …

Check Point Software Reports 2025 First Quarter Financial Results
TEL AVIV, Israel, April 23, 2025 (GLOBE NEWSWIRE) -- Check Point® Software Technologies Ltd. (NASDAQ: CHKP), today announced its financial results for the quarter ended March 31st, 2025. First Quarter 2025 Financial Highlights: Cash Flow from Operations: $ …

Orion Group Interim Report January–March 2025
ORION CORPORATION INTERIM REPORT 1–3/2025 23 APRIL 2025 at 12:00 EEST Orion Group Interim Report January–March 2025 January–March 2025 Highlights Net sales totalled EUR 354.6 (January–March 2024: 308.5) million Operating profit was EUR 77.9 (56.0) million …

Orion-konsernin osavuosikatsaus tammi–maaliskuu 2025
ORION OYJ OSAVUOSIKATSAUS 1–3/2025 23.4.2025 klo 12:00 Orion-konsernin osavuosikatsaus tammi–maaliskuu 2025 Tammi–maaliskuu 2025 lyhyesti Liikevaihto oli 354,6 miljoonaa euroa (308,5 miljoonaa euroa 1–3/2024) Liikevoitto oli 77,9 (56,0) miljoonaa euroa …

Tandem Workforce and NuPaths Partner to Address the IT Talent Shortage with Scalable, Retention-Focused Model
ENOLA, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- Tandem Workforce and NuPaths today unveiled a first-of-its-kind collaboration that promises to transform how companies build and maintain their IT departments. This innovative partnership combines NuPaths' …

Barebone Budgeting Launches on the App Store to Help Uncover Hidden Expenses
Washington, DC, April 23, 2025 (GLOBE NEWSWIRE) -- As living expenses continue to rise and household budgets face increasing pressures, many individuals feel they’ve exhausted all possible ways to cut back. Barebone Budgeting has officially launched on the …

Boehringer Ingelheim and Tessellate Bio partner to develop first-in-class precision treatments for people with hard-to-treat cancers
Ingelheim, Germany and Amsterdam, the Netherlands, 23 April 2025 – Boehringer Ingelheim and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, have entered into a research collaboration and global …

Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS
For media and investors only Joenja® is the first and only medicine specifically for APDS to be reimbursed within the NHS Recommended for adult and pediatric patients 12 years of age and older with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome …

Cytovation Raises US$6m to Advance Phase 2 Development of CY-101 in Adrenocortical Carcinoma to First Clinical Readouts
New funds provided largely by existing investors, led by Sandwater Phase 2 trial to be delivered through novel agreement between Cytovation, Cancer Research UK and the Norwegian Cancer Society New preclinical data highlighting potential of CY-101 in ACC …

Boehringer Ingelheim and Tessellate Bio partner to develop first-in-class precision treatments for people with hard-to-treat cancers
INGELHEIM, Germany and AMSTERDAM, April 23, 2025 (GLOBE NEWSWIRE) -- Boehringer Ingelheim and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, have entered into a research collaboration and …

Antag Therapeutics expands senior team to support clinical progress
Copenhagen, Denmark, 23 April 2025 – Antag Therapeutics (“Antag” or “the Company”), a biopharmaceutical company pioneering novel treatments for obesity, today announces the appointment of three new hires to support the Company’s next phase of growth …

Codex Labs Bia Ultra-Hydrating Soothing Lotion Is Awarded Seal of Acceptance from National Eczema Association and Microbiome-Friendly Certification from MyMicrobiome
San Jose, CA, USA, April 23, 2025 (GLOBE NEWSWIRE) -- Codex Labs, a Silicon Valley skintech company, announced that its Bia Ultra-Hydrating Soothing Lotion, the European version of its US Bia over-the-counter (OTC) Bia Eczema Relief Lotion has been awarded …